The clinical and economic burden of chronic obstructive pulmonary disease in the USA
Shaunta’ M. Ray, Guarascio, Christopher K. Finch, Tim Self
- ISSN / E-ISSN
- — / —
- DOI
- 10.2147/ceor.s34321 ↗
- Volume · Issue · Pages
- 5 · — · 235-235
- Publisher
- Dove Medical Press Ltd.
- Article URL
- https://doi.org/10.2147/ceor.s34321 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Jun 2013
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Jun 2013 | OpenAlex |
Keywords (as given): chronic obstructive pulmonary disease; economic burden; health care costs; COPD diagnosis; smoking cessation; COPD exacerbations; bronchodilators; long-acting beta2-agonists; long-acting muscarinic antagonist; inhaled corticosteroids; triple therapy; phosphodiesterase-4 inhibitors; disease severity
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- ClinicoEconomics and Outcomes Research
- Publication date used
- 01 Jun 2013 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.